Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Guardian Pharmacy Services, Inc. Class A Common Stock (NY:GRDN)

24.32 -0.09 (-0.39%)
Streaming Delayed Price Updated: 3:38 PM EDT, Oct 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Guardian Pharmacy Services, Inc. Class A Common Stock

< Previous 1 2 Next >
Self-Driving Startup Pony.ai Files For U.S. IPO
Self-driving startup Pony.ai of China filed for an IPO in the U.S. this week. Meanwhile, four companies -- Springview Holdings, Oriental Rise Holdings, PTL Limited, and Samfine Creation Holdings Group... 
Via Talk Markets
Topics Initial Public Offering
Obesity Drug Developer BioAge Makes Nasdaq Debut
Shares of BioAge Labs opened for trading this week, with the company planning to use the proceeds of its initial public offering to take its lead obesity drug further into clinical trials. 
Via Talk Markets
Earnings Scheduled For November 12, 2024
 
Via Benzinga
Guardian Pharmacy Services, Inc. to Participate in Upcoming Investor Conference
From Guardian Pharmacy Services, Inc.
Via Business Wire
Guardian Pharmacy Services, Inc. to Report Third Quarter 2024 Financial Results and Host Conference Call
From Guardian Pharmacy Services, Inc.
Via Business Wire
Newly Listed Guardian Pharmacy Is Well Positioned In Highly Fragmented Market, Analyst Initiates With Buy Rating
Truist initiates coverage of Guardian Pharmacy, projecting a $22 price target due to strong growth in the $24.8 billion institutional pharmacy market. 
Via Benzinga
This GE Vernova Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
 
Via Benzinga
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.